An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer
暂无分享,去创建一个
Eytan Ruppin | Keren Yizhak | Noam Auslander | E. Ruppin | Keren Yizhak | F. Vizeacoumar | Noam Auslander | F. Vizeacoumar | A. Freywald | Franco J Vizeacoumar | Sreejit Parameswaran | T. Freywald | Andrew Freywald | Frederick S Vizeacoumar | Sreejit Parameswaran | Chelsea E Cunningham | Behzad M Toosi | Emily J McEwen | Nir Gonen | Tanya Freywald | Kalpana K Bhanumathy | Nir Gonen | Chelsea E. Cunningham | Emily McEwen | Behzad M. Toosi | K. Bhanumathy
[1] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[2] M. Hung,et al. Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells , 2016, Nature Communications.
[3] Ken Chen,et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.
[4] S. Hakomori. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.
[5] V. Dixit,et al. Ubiquitin in the activation and attenuation of innate antiviral immunity , 2016, The Journal of experimental medicine.
[6] K. Kinzler,et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.
[7] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[8] L. Ricci-Vitiani,et al. Colon cancer stem cells , 2007, Gut.
[9] Eytan Ruppin,et al. A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration , 2014, Molecular Systems Biology.
[10] John D Potter,et al. Transcription Factor 7–like 2 Polymorphism and Colon Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[11] Aarash Bordbar,et al. A Systems Approach to Predict Oncometabolites via Context-Specific Genome-Scale Metabolic Networks , 2014, PLoS Comput. Biol..
[12] Hans Clevers,et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.
[13] T. Wakano,et al. Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. , 2001, International journal of oncology.
[14] V. Weaver,et al. Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells , 2016, The Journal of experimental medicine.
[15] C. Feschotte,et al. Endogenous viruses: insights into viral evolution and impact on host biology , 2012, Nature Reviews Genetics.
[16] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[17] S. Hsu,et al. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells , 2006, Oncogene.
[18] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[19] J. Nielsen,et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling , 2014, Molecular systems biology.
[20] J. Lloreta,et al. EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells , 2007, Nature Genetics.
[21] M. Kurimoto,et al. Ley glycolipid acts as a co‐factor for tumor procoagulant activity , 1997, International journal of cancer.
[22] John M. Asara,et al. Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.
[23] J. Esko,et al. The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.
[24] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[25] Emanuel J. V. Gonçalves,et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition , 2016, Nature.
[26] 이연수. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .
[27] C. Morrison,et al. PTEN mutations are common in sporadic microsatellite stable colorectal cancer , 2004, Oncogene.
[28] Udo Schumacher,et al. Relevance of βGal–βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients , 2015, Breast Cancer Research and Treatment.
[29] Natapol Pornputtapong,et al. Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT , 2012, PLoS Comput. Biol..
[30] S. Haan,et al. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies , 2017, Molecular Cancer.
[31] S. Chiou,et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. , 2010, Cancer research.
[32] G. Church,et al. Analysis of optimality in natural and perturbed metabolic networks , 2002 .
[33] M. Schachner,et al. Expression of glycogenes in differentiating human NT2N neurons. Downregulation of fucosyltransferase 9 leads to decreased Lewis(x) levels and impaired neurite outgrowth. , 2012, Biochimica et biophysica acta.
[34] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[35] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[36] B. Delahunt,et al. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. , 2002, Cancer research.
[37] R. DiPaola,et al. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer , 2016, Clinical Cancer Research.
[38] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[39] D. Steindler,et al. Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. , 2009, Cancer research.
[40] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[41] E. Fearon. Genetic alterations underlying colorectal tumorigenesis. , 1992, Cancer surveys.
[42] Jeffrey T. Chang,et al. Anchorage-independent cell growth signature identifies tumors with metastatic potential , 2009, Oncogene.
[43] Hiroshi Tanaka,et al. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile. , 2012, Cancer genomics & proteomics.
[44] C. Liang,et al. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.
[45] C. Blanpain,et al. Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.
[46] Hung-Ming Wang,et al. Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer , 2011, Clinical Cancer Research.
[47] Andrew T. Chan,et al. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk , 2008, Cancer Causes & Control.
[48] K. Shitara,et al. Alpha1,3-fucosyltransferase IX (Fut9) determines Lewis X expression in brain. , 2003, Glycobiology.
[49] Eytan Ruppin,et al. Model-based identification of drug targets that revert disrupted metabolism and its application to ageing , 2013, Nature Communications.
[50] Bernhard O. Palsson,et al. Context-Specific Metabolic Networks Are Consistent with Experiments , 2008, PLoS Comput. Biol..
[51] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[52] J. Morgado-Díaz,et al. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications , 2015, Oncotarget.
[53] Y. Rombouts,et al. Glycosylation characteristics of colorectal cancer. , 2015, Advances in cancer research.
[54] Eyal Gottlieb,et al. Inborn and acquired metabolic defects in cancer , 2011, Journal of Molecular Medicine.
[55] Michal A. Kurowski,et al. Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.
[56] B. Lim,et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression , 2016, Nature Communications.
[57] W F Bodmer,et al. The ABC of APC. , 2001, Human molecular genetics.
[58] Jukka-Pekka Mecklin,et al. SMAD4 as a Prognostic Marker in Colorectal Cancer , 2005, Clinical Cancer Research.
[59] S. Hakomori,et al. Novel fucolipids of human adenocarcinoma: characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI2FucnLc6). , 1986, The Journal of biological chemistry.
[60] J. Wrana,et al. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells. , 2011, Cancer research.
[61] O. Demin,et al. The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.
[62] M. Taketo,et al. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.
[63] M. Król,et al. Identification and characterization of cancer stem cells in canine mammary tumors , 2016, Acta Veterinaria Scandinavica.
[64] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[65] Larry A. Sklar,et al. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia , 2016, Cell.
[66] H. Ishida,et al. A novel β1,3‐N‐acetylglucosaminyltransferase (β3Gn‐T8), which synthesizes poly‐N‐acetyllactosamine, is dramatically upregulated in colon cancer , 2005, FEBS letters.
[67] H. Lenz,et al. Molecular prognostic markers in locally advanced colon cancer. , 2007, Clinical colorectal cancer.
[68] Jeffrey D Orth,et al. What is flux balance analysis? , 2010, Nature Biotechnology.
[69] H. O’Neill,et al. Oncogenesis and cancer stem cells: current opinions and future directions , 2009, Journal of cellular and molecular medicine.
[70] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[71] S. Su,et al. IDH mutations in glioma and acute myeloid leukemia. , 2010, Trends in molecular medicine.
[72] Masahide Takahashi,et al. Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis , 2016, International journal of oncology.